Q32 Bio (QTTB) Total Current Liabilities (2017 - 2026)

Q32 Bio's Total Current Liabilities history runs 10 years deep, the most recent figure standing at $10.7 million for Q1 2026.

• On a quarterly basis, Total Current Liabilities fell 26.82% year-over-year to $10.7 million in Q1 2026; TTM through Mar 2026 was $10.7 million, a 26.82% decrease from a year earlier, with the FY2025 full-year figure at $11.3 million, down 31.09% from the prior year.
• Total Current Liabilities declined to $10.7 million in Q1 2026 per QTTB's latest filing, from $11.3 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $33.0 million in Q1 2024 and bottomed at $10.7 million in Q1 2026.
• The 5-year median for Total Current Liabilities is $17.2 million (2024), against an average of $18.3 million.
• Across the five-year window, Total Current Liabilities surged 78.06% in 2024 and sank 55.76% in 2025, its largest moves.
• Year by year, Total Current Liabilities stood at $22.6 million in 2022, then tumbled by 37.5% to $14.1 million in 2023, then gained by 16.7% to $16.5 million in 2024, then slumped by 31.09% to $11.3 million in 2025, then dropped by 5.97% to $10.7 million in 2026.
• Per Business Quant, the three latest QTTB Total Current Liabilities figures stand at $10.7 million (Q1 2026), $11.3 million (Q4 2025), and $11.1 million (Q3 2025).